Tomohisa Nagoshi

2.3k total citations
75 papers, 1.8k citations indexed

About

Tomohisa Nagoshi is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Epidemiology. According to data from OpenAlex, Tomohisa Nagoshi has authored 75 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Cardiology and Cardiovascular Medicine, 19 papers in Surgery and 14 papers in Epidemiology. Recurrent topics in Tomohisa Nagoshi's work include Cardiovascular Function and Risk Factors (19 papers), Heart Failure Treatment and Management (18 papers) and Cardiac Imaging and Diagnostics (8 papers). Tomohisa Nagoshi is often cited by papers focused on Cardiovascular Function and Risk Factors (19 papers), Heart Failure Treatment and Management (18 papers) and Cardiac Imaging and Diagnostics (8 papers). Tomohisa Nagoshi collaborates with scholars based in Japan, United States and France. Tomohisa Nagoshi's co-authors include Michihiro Yoshimura, Anthony Rosenzweig, Takashi Matsui, Justina Wu, Stuart A. Cook, Michael H. Picard, Ronglih Liao, Ling Li, Toshikazu Tanaka and Yusuke Kashiwagi and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Journal of Clinical Investigation.

In The Last Decade

Tomohisa Nagoshi

68 papers receiving 1.8k citations

Peers

Countries citing papers authored by Tomohisa Nagoshi

Since Specialization

Citations

This map shows the geographic impact of Tomohisa Nagoshi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomohisa Nagoshi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomohisa Nagoshi more than expected).

Fields of papers citing papers by Tomohisa Nagoshi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomohisa Nagoshi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomohisa Nagoshi. The network helps show where Tomohisa Nagoshi may publish in the future.

Co-authorship network of co-authors of Tomohisa Nagoshi

This figure shows the co-authorship network connecting the top 25 collaborators of Tomohisa Nagoshi. A scholar is included among the top collaborators of Tomohisa Nagoshi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomohisa Nagoshi. Tomohisa Nagoshi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	An Endocrine-Disrupting Chemical, Bisphenol A Diglycidyl Ether (BADGE), Accelerates Neuritogenesis and Outgrowth of Cortical Neurons via the G-Protein-Coupled Estrogen Receptor 2025 ·NeuroSci ·Ikuko Miyazaki, (unknown), Tomohisa Nagoshi, (unknown), (unknown), (unknown), (unknown), Kazuhiko Tomimoto, Kaori Masai, (unknown), Masato Asanuma	0
2	Blunted increase in plasma BNP during acute coronary syndrome attacks in obese patients 2024 ·IJC Heart & Vasculature ·(unknown), Tomohisa Nagoshi, (unknown), Toshikazu Tanaka, Yuhei Oi, Haruka Kimura, Yusuke Kashiwagi, Kazuo Ogawa, Kosuke Minai, Takayuki Ogawa, Makoto Kawai, Michihiro Yoshimura	0
3	Cut-off values of Geriatric Nutritional Risk Index for cardiovascular events in Japanese patients with acute myocardial infarction 2024 ·Heart and Vessels ·(unknown), (unknown), Tomohisa Nagoshi, (unknown), Yusuke Kashiwagi, Satoshi Morimoto, Kazuo Ogawa, Kosuke Minai, Takayuki Ogawa, Michihiro Yoshimura	0
4	URAT1 is expressed in cardiomyocytes and dotinurad attenuates the development of diet-induced metabolic heart disease 2023 ·iScience ·Yoshiro Tanaka, Tomohisa Nagoshi, (unknown), Yuhei Oi, (unknown), Akira Yoshii, Haruka Kimura, Yusuke Kashiwagi, Toshikazu Tanaka, Masayuki Shimoda, Michihiro Yoshimura	6
5	Inhibitory action of B-type natriuretic peptide on adrenocorticotropic hormone in patients with acute coronary syndrome 2023 ·American Journal of Physiology-Heart and Circulatory Physiology ·(unknown), (unknown), Tomohisa Nagoshi, (unknown), Toshikazu Tanaka, Yuhei Oi, Yusuke Kashiwagi, (unknown), Kazuo Ogawa, Kosuke Minai, Takayuki Ogawa, Makoto Kawai, Michihiro Yoshimura	1
6	Effects of Angiotensin Receptor-Neprilysin Inhibitor on Insulin Resistance in Patients with Heart Failure 2023 ·ESC Heart Failure ·Yusuke Kashiwagi, Tomohisa Nagoshi, Haruka Kimura, Yoshiro Tanaka, Yuhei Oi, (unknown), Kazuo Ogawa, Makoto Kawai, Michihiro Yoshimura	3
7	Time-dependent changes in P2Y12 reaction unit values for predicting the different types of cardiovascular events in patients with ischemic heart disease 2023 ·Heart and Vessels ·(unknown), (unknown), (unknown), Satoshi Morimoto, Kazuo Ogawa, Tomohisa Nagoshi, Kosuke Minai, Takayuki Ogawa, Makoto Kawai, Michihiro Yoshimura	2
8	Exogenous ANP Treatment Ameliorates Myocardial Insulin Resistance and Protects against Ischemia–Reperfusion Injury in Diet-Induced Obesity 2022 ·International Journal of Molecular Sciences ·Yuhei Oi, Tomohisa Nagoshi, Haruka Kimura, Yoshiro Tanaka, Akira Yoshii, (unknown), (unknown), Yusuke Kashiwagi, Toshikazu Tanaka, Toshiaki Tachibana, Michihiro Yoshimura	7
9	URAT1-selective inhibition ameliorates insulin resistance by attenuating diet-induced hepatic steatosis and brown adipose tissue whitening in mice 2021 ·Molecular Metabolism ·Yoshiro Tanaka, Tomohisa Nagoshi, (unknown), Yuhei Oi, Akira Yoshii, Haruka Kimura, Keiichi Ito, Yusuke Kashiwagi, Toshikazu Tanaka, Michihiro Yoshimura	39
10	Treatment with atrial natriuretic peptide induces adipose tissue browning and exerts thermogenic actions in vivo 2021 ·Scientific Reports ·Haruka Kimura, Tomohisa Nagoshi, Yuhei Oi, Akira Yoshii, Yoshiro Tanaka, (unknown), Yusuke Kashiwagi, Toshikazu Tanaka, Michihiro Yoshimura	34
11	Xanthine oxidase inhibition attenuates doxorubicin-induced cardiotoxicity in mice 2020 ·Free Radical Biology and Medicine ·Yoshiro Tanaka, Tomohisa Nagoshi, Akira Yoshii, Yuhei Oi, (unknown), Haruka Kimura, Keiichi Ito, Yusuke Kashiwagi, Toshikazu Tanaka, Michihiro Yoshimura	28
12	Cardiac ischemia–reperfusion injury under insulin-resistant conditions: SGLT1 but not SGLT2 plays a compensatory protective role in diet-induced obesity 2019 ·Cardiovascular Diabetology ·Akira Yoshii, Tomohisa Nagoshi, Yusuke Kashiwagi, Haruka Kimura, Yoshiro Tanaka, Yuhei Oi, Keiichi Ito, Takuya Yoshino, Toshikazu Tanaka, Michihiro Yoshimura	36
13	Association between plasma B-type natriuretic peptide and anaemia in heart failure with or without ischaemic heart disease: a retrospective study 2019 ·BMJ Open ·Mitsutoshi Tominaga, Makoto Kawai, Kosuke Minai, Kazuo Ogawa, (unknown), Satoshi Morimoto, Toshikazu Tanaka, Tomohisa Nagoshi, Takayuki Ogawa, Michihiro Yoshimura	7
14	Collaborative Activities of Noradrenaline and Natriuretic Peptide for Glucose Utilization in Patients with Acute Coronary Syndrome 2019 ·Scientific Reports ·(unknown), Tomohisa Nagoshi, Akira Yoshii, (unknown), Yoshiro Tanaka, Haruka Kimura, Satoshi Ito, Kazuo Ogawa, Toshikazu Tanaka, Kosuke Minai, Takayuki Ogawa, Makoto Kawai, Michihiro Yoshimura	9
15	Possible increase in insulin resistance and concealed glucose-coupled potassium-lowering mechanisms during acute coronary syndrome documented by covariance structure analysis 2017 ·PLoS ONE ·Satoshi Ito, Tomohisa Nagoshi, Kosuke Minai, Yusuke Kashiwagi, Hiroshi Sekiyama, Akira Yoshii, Haruka Kimura, (unknown), Kazuo Ogawa, Toshikazu Tanaka, Takayuki Ogawa, Makoto Kawai, Michihiro Yoshimura	14
16	Manifold implications of obesity in ischemic heart disease among Japanese patients according to covariance structure analysis: Low reactivity of B-type natriuretic peptide as an intervening risk factor 2017 ·PLoS ONE ·(unknown), Kosuke Minai, Makoto Kawai, Kazuo Ogawa, (unknown), Satoshi Morimoto, Toshikazu Tanaka, Tomohisa Nagoshi, Takayuki Ogawa, Michihiro Yoshimura	12
17	A Pilot Study for Evaluating the Longitudinal Strength and Flexibility of Coronary Stents: Results of a Bench Test (Original) 2015 ·Takayuki Ogawa, (unknown), (unknown), Tomohisa Nagoshi, (unknown), Michihiro Yoshimura	2
18	A Pilot Study for A Bench Test of the Mechanical Properties of the Platforms for Second-generation Drug-eluting Stents (Original) 2014 ·Takayuki Ogawa, (unknown), Tomohisa Nagoshi, (unknown), Michihiro Yoshimura	2
19	The role of Na+/H+ exchanger in Ca2+ overload and ischemic myocardial damage in hearts from type 2 diabetic db/db mice 2012 ·Cardiovascular Diabetology ·(unknown), Shingo Seki, Tomohisa Nagoshi, Ikuo Taniguchi, D. Feuvray, Michihiro Yoshimura	26
20	High Incidence of Repeat Anginal Attacks Despite Treatment With Calcium-Channel Blockers in Patients With Coronary Spastic Angina(Ischemic Heart Disease) 2009 ·Japanese Circulation Journal-english Edition ·Takayuki Ogawa, Kimiaki Komukai, Kazuo Ogawa, (unknown), Tomohisa Nagoshi, Kosuke Minai, Hiroshi Sakamoto, Koichi Hashimoto, Satoru Yoshida, Ikuo Taniguchi, Seibu Mochizuki, Michihiro Yoshimura	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact